{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:28:19Z","timestamp":1793824099883,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2023-19938\/F1"],"award-info":[{"award-number":["2023-19938\/F1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11095-026-04198-x","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:30:52Z","timestamp":1789432252000},"page":"3505-3524","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy"],"prefix":"10.1007","volume":"43","author":[{"given":"Aaditi","family":"Karnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish Siddanagouda","family":"Hosmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Dolma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gangopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Lalwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh Babu","family":"Boga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punna Rao","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-1035","authenticated-orcid":false,"given":"Abhijeet R.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"11","key":"4198_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jnnp-2021-328323","volume":"94","author":"SB Park","year":"2023","unstructured":"Park SB, Cetinkaya-Fisgin A, Argyriou AA, H\u00f6ke A, Cavaletti G, Alberti P. Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. J Neurol Neurosurg Psychiatry. 2023;94(11):962\u201372. https:\/\/doi.org\/10.1136\/jnnp-2021-328323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4198_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129920","author":"S Geisler","year":"2019","unstructured":"Geisler S, Doan RA, Cheng GC, Cetinkaya-Fisgin A, Huang SX, H\u00f6ke A, et al. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.129920.","journal-title":"JCI Insight"},{"issue":"7","key":"4198_CR3","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1007\/s12035-025-04835-3","volume":"62","author":"A Karnik","year":"2025","unstructured":"Karnik A, Joshi A. SARM1: the checkpoint of axonal degeneration in the nervous system disorders. Mol Neurobiol. 2025;62(7):9240\u201357. https:\/\/doi.org\/10.1007\/s12035-025-04835-3.","journal-title":"Mol Neurobiol"},{"issue":"6233","key":"4198_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","volume":"348","author":"J Gerdts","year":"2015","unstructured":"Gerdts J, Brace EJ, Sasaki Y, DiAntonio A, Milbrandt J. SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science. 2015;348(6233):453\u20137. https:\/\/doi.org\/10.1126\/science.1258366.","journal-title":"Science"},{"key":"4198_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2022.958900","volume":"25","author":"TJ Waller","year":"2022","unstructured":"Waller TJ, Collins CA. Multifaceted roles of SARM1 in axon degeneration and signaling. Front Cell Neurosci. 2022;25:16. https:\/\/doi.org\/10.3389\/fncel.2022.958900.","journal-title":"Front Cell Neurosci"},{"key":"4198_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129920","author":"S Geisler","year":"2019","unstructured":"Geisler S, Doan RA, Cheng GC, Cetinkaya-Fisgin A, Huang SX, H\u00f6ke A, et al. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.129920.","journal-title":"JCI Insight"},{"issue":"12","key":"4198_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41419-023-06227-8","volume":"14","author":"J Gomez-Deza","year":"2023","unstructured":"Gomez-Deza J, Slavutsky AL, Nebiyou M, Le Pichon CE. Local production of reactive oxygen species drives vincristine-induced axon degeneration. Cell Death Dis. 2023;14(12):807. https:\/\/doi.org\/10.1038\/s41419-023-06227-8.","journal-title":"Cell Death Dis"},{"issue":"12","key":"4198_CR8","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/brain\/aww251","volume":"139","author":"S Geisler","year":"2016","unstructured":"Geisler S, Doan RA, Strickland A, Huang X, Milbrandt J, DiAntonio A. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain. 2016;139(12):3092\u2013108. https:\/\/doi.org\/10.1093\/brain\/aww251.","journal-title":"Brain"},{"issue":"9","key":"4198_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092123","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Li H. Characterization of novel SARM1 inhibitors for the treatment of chemotherapy-induced peripheral neuropathy. Biomedicines. 2024;12(9):2123. https:\/\/doi.org\/10.3390\/biomedicines12092123.","journal-title":"Biomedicines"},{"issue":"10","key":"4198_CR10","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1093\/brain\/awab184","volume":"144","author":"T Bosanac","year":"2021","unstructured":"Bosanac T, Hughes RO, Engber T, Devraj R, Brearley A, Danker K, et al. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy. Brain. 2021;144(10):3226\u201338. https:\/\/doi.org\/10.1093\/brain\/awab184.","journal-title":"Brain"},{"issue":"22","key":"4198_CR11","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.neuron.2022.08.017","volume":"110","author":"M Bratkowski","year":"2022","unstructured":"Bratkowski M, Burdett TC, Danao J, Wang X, Mathur P, Gu W, et al. Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron. 2022;110(22):3711-3726.e16. https:\/\/doi.org\/10.1016\/j.neuron.2022.08.017.","journal-title":"Neuron"},{"issue":"Pt 6 No 1","key":"4198_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/s0907444902003451","volume":"58","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6 No 1):899\u2013907. https:\/\/doi.org\/10.1107\/s0907444902003451.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"9","key":"4198_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","volume":"82","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kerry PS, Nanson JD, Bosanac T, Sasaki Y, Krauss R, et al. Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules. Mol Cell. 2022;82(9):1643-1659.e10. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.007.","journal-title":"Mol Cell"},{"issue":"3","key":"4198_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/s0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson MP, Friesner RA, Xiang Z, Honig B. On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol. 2002;320(3):597\u2013608. https:\/\/doi.org\/10.1016\/s0022-2836(02)00470-9.","journal-title":"J Mol Biol"},{"issue":"2","key":"4198_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, et al. A hierarchical approach to all-atom protein loop prediction. Proteins Struct Funct Bioinforma. 2004;55(2):351\u201367. https:\/\/doi.org\/10.1002\/prot.10613.","journal-title":"Proteins Struct Funct Bioinforma"},{"issue":"3","key":"4198_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221\u201334. https:\/\/doi.org\/10.1007\/s10822-013-9644-8.","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"4198_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH. PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theory Comput. 2011;7(2):525\u201337. https:\/\/doi.org\/10.1021\/ct100578z.","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"4198_CR18","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, et al. OPLS4: Improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput. 2021;17(7):4291\u2013300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302.","journal-title":"J Chem Theory Comput"},{"key":"4198_CR19","unstructured":"Schr\u00f6dinger Release 2021\u20132: LigPrep, Schr\u00f6dinger, LLC, New York. NY: Schr\u00f6dinger, LLC, New York; 2021."},{"issue":"12","key":"4198_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL, Greenwood JR, TimLin MR, Uchimaya M. Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007;21(12):681\u201391. https:\/\/doi.org\/10.1007\/s10822-007-9133-z.","journal-title":"J Comput Aided Mol Des"},{"issue":"21","key":"4198_CR21","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49(21):6177\u201396. https:\/\/doi.org\/10.1021\/jm051256o.","journal-title":"J Med Chem"},{"issue":"7","key":"4198_CR22","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47(7):1750\u20139. https:\/\/doi.org\/10.1021\/jm030644s.","journal-title":"J Med Chem"},{"issue":"7","key":"4198_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739\u201349. https:\/\/doi.org\/10.1021\/jm0306430.","journal-title":"J Med Chem"},{"key":"4198_CR24","unstructured":"Maestro Release 2021\u20132; Schr\u00f6dinger. Maestro Release 2021\u20132; Schr\u00f6dinger. 2021."},{"issue":"10","key":"4198_CR25","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1093\/brain\/awab184","volume":"144","author":"T Bosanac","year":"2021","unstructured":"Bosanac T, Hughes RO, Engber T, Devraj R, Brearley A, Danker K, et al. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy. Brain. 2021;144(10):3226. https:\/\/doi.org\/10.1093\/brain\/awab184.","journal-title":"Brain"},{"issue":"1","key":"4198_CR26","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.celrep.2020.108588","volume":"34","author":"RO Hughes","year":"2021","unstructured":"Hughes RO, Bosanac T, Mao X, Engber TM, DiAntonio A, Milbrandt J, et al. Small molecule SARM1 inhibitors recapitulate the SARM1\u2212\/\u2212 phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep. 2021;34(1):108588. https:\/\/doi.org\/10.1016\/j.celrep.2020.108588.","journal-title":"Cell Rep"},{"issue":"1","key":"4198_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12974-018-1116-6","volume":"15","author":"K Montague","year":"2018","unstructured":"Montague K, Simeoli R, Valente J, Malcangio M. A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain. J Neuroinflammation. 2018;15(1):101. https:\/\/doi.org\/10.1186\/s12974-018-1116-6.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4198_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9.","journal-title":"J Neurosci Methods"},{"key":"4198_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fphar.2018.00433","volume":"1","author":"R Gonzalez-Cano","year":"2018","unstructured":"Gonzalez-Cano R, Boivin B, Bullock D, Cornelissen L, Andrews N, Costigan M. Up\u2013down reader: An open source program for efficiently processing 50% Von Frey thresholds. Front Pharmacol. 2018;1:9. https:\/\/doi.org\/10.3389\/fphar.2018.00433.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4198_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32(1):77\u201388. https:\/\/doi.org\/10.1016\/0304-3959(88)90026-7.","journal-title":"Pain"},{"issue":"5","key":"4198_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1601-183X.2006.00268.x","volume":"6","author":"S Choi","year":"2007","unstructured":"Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, et al. Attenuated pain responses in mice lacking CaV3.2 T-type channels. Genes Brain Behav. 2007;6(5):425\u201331. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00268.x.","journal-title":"Genes Brain Behav"},{"key":"4198_CR32","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.neuropharm.2025.110678","volume":"280","author":"S Dolma","year":"2025","unstructured":"Dolma S, Karnik A, Sanjeev R, Ghosh B, Joshi AR. Selective inhibition of histone deacetylase 3 (HDAC3) prevents vincristine-induced peripheral neuropathy via macrophage polarization. Neuropharmacology. 2025;280:110678. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110678.","journal-title":"Neuropharmacology"},{"issue":"1","key":"4198_CR33","doi-asserted-by":"publisher","first-page":"19341","DOI":"10.1038\/s41598-024-70294-w","volume":"14","author":"I Utkina-Sosunova","year":"2024","unstructured":"Utkina-Sosunova I, Chiorazzi A, de Planell-Saguer M, Li H, Meregalli C, Pozzi E, et al. Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation. Sci Rep. 2024;14(1):19341. https:\/\/doi.org\/10.1038\/s41598-024-70294-w.","journal-title":"Sci Rep"},{"key":"4198_CR34","doi-asserted-by":"publisher","first-page":"52434","DOI":"10.3791\/52434","volume":"96","author":"ML Seibenhener","year":"2015","unstructured":"Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp JoVE. 2015;96:52434. https:\/\/doi.org\/10.3791\/52434.","journal-title":"J Vis Exp JoVE"},{"issue":"8","key":"4198_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ejhg.2008.21","volume":"16","author":"S Girirajan","year":"2008","unstructured":"Girirajan S, Patel N, Slager RE, Tokarz ME, Bucan M, Wiley JL, et al. How much is too much? Phenotypic consequences of Rai1 overexpression in mice. Eur J Hum Genet. 2008;16(8):941\u201354. https:\/\/doi.org\/10.1038\/ejhg.2008.21.","journal-title":"Eur J Hum Genet"},{"issue":"72","key":"4198_CR36","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1016\/j.fbio.2025.107501","volume":"1","author":"RJ Gao","year":"2025","unstructured":"Gao RJ, Sun L, Zhou SD, Liu YM, Qiu WQ, Yang SP, et al. Molecular docking screening of endogenous protease inhibitors in sea bass (Lates calcarifer) and in vitro validation of their inhibitory efficacy. Food Biosci. 2025;1(72):107501. https:\/\/doi.org\/10.1016\/j.fbio.2025.107501.","journal-title":"Food Biosci"},{"issue":"6","key":"4198_CR37","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","volume":"93","author":"K Essuman","year":"2017","unstructured":"Essuman K, Summers DW, Sasaki Y, Mao X, DiAntonio A, Milbrandt J. The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration. Neuron. 2017;93(6):1334-1343.e5. https:\/\/doi.org\/10.1016\/j.neuron.2017.02.022.","journal-title":"Neuron"},{"issue":"6455","key":"4198_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.aax1911","volume":"365","author":"S Horsefield","year":"2019","unstructured":"Horsefield S, Burdett H, Zhang X, Manik MK, Shi Y, Chen J, et al. NAD+ cleavage activity by animal and plant TIR domains in cell death pathways. Science. 2019;365(6455):793\u20139. https:\/\/doi.org\/10.1126\/science.aax1911.","journal-title":"Science"},{"issue":"1","key":"4198_CR39","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.celrep.2020.108588","volume":"34","author":"RO Hughes","year":"2021","unstructured":"Hughes RO, Bosanac T, Mao X, Engber TM, DiAntonio A, Milbrandt J, et al. Small molecule SARM1 inhibitors recapitulate the SARM1\u2212\/\u2212 phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep. 2021;34(1):108588. https:\/\/doi.org\/10.1016\/j.celrep.2020.108588.","journal-title":"Cell Rep"},{"issue":"1","key":"4198_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0006-8993(97)81682-4","volume":"774","author":"PC Contreras","year":"1997","unstructured":"Contreras PC, Vaught JL, Gruner JA, Brosnan C, Steffler C, Arezzo JC, et al. Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice. Brain Res. 1997;774(1):20\u20136. https:\/\/doi.org\/10.1016\/S0006-8993(97)81682-4.","journal-title":"Brain Res"},{"key":"4198_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2017.11.011","volume":"111","author":"L Van Helleputte","year":"2018","unstructured":"Van Helleputte L, Kater M, Cook DP, Eykens C, Rossaert E, Haeck W, et al. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiol Dis. 2018;111:59\u201369. https:\/\/doi.org\/10.1016\/j.nbd.2017.11.011.","journal-title":"Neurobiol Dis"},{"key":"4198_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cnp.2024.04.002","volume":"9","author":"PE Barkhaus","year":"2024","unstructured":"Barkhaus PE, Nandedkar SD, de Carvalho M, Swash M, St\u00e5lberg EV. Revisiting the compound muscle action potential (CMAP). Clin Neurophysiol Pract. 2024;9:176\u2013200. https:\/\/doi.org\/10.1016\/j.cnp.2024.04.002.","journal-title":"Clin Neurophysiol Pract"},{"issue":"3","key":"4198_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1529-8027.2006.0090.x","volume":"11","author":"A Silva","year":"2006","unstructured":"Silva A, Wang Q, Wang M, Ravula SK, Glass JD. Evidence for direct axonal toxicity in vincristine neuropathy. J Peripher Nerv Syst. 2006;11(3):211\u20136. https:\/\/doi.org\/10.1111\/j.1529-8027.2006.0090.x.","journal-title":"J Peripher Nerv Syst"},{"key":"4198_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","volume":"37","author":"NE LaPointe","year":"2013","unstructured":"LaPointe NE, Morfini G, Brady ST, Feinstein SC, Wilson L, Jordan MA. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology. 2013;37:231\u20139. https:\/\/doi.org\/10.1016\/j.neuro.2013.05.008.","journal-title":"Neurotoxicology"},{"issue":"18","key":"4198_CR45","doi-asserted-by":"publisher","first-page":"115644","DOI":"10.1016\/j.bmc.2020.115644","volume":"28","author":"HS Loring","year":"2020","unstructured":"Loring HS, Parelkar SS, Mondal S, Thompson PR. Identification of the First Noncompetitive SARM1 Inhibitors. Bioorg Med Chem. 2020;28(18):115644. https:\/\/doi.org\/10.1016\/j.bmc.2020.115644.","journal-title":"Bioorg Med Chem"},{"key":"4198_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092123","author":"J Chen","year":"2024","unstructured":"Chen J, Li H. Characterization of novel SARM1 inhibitors for the treatment of chemotherapy-induced peripheral neuropathy. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12092123.","journal-title":"Biomedicines"},{"issue":"35","key":"4198_CR47","doi-asserted-by":"publisher","first-page":"e2208457119","DOI":"10.1073\/pnas.2208457119","volume":"119","author":"HC Feldman","year":"2022","unstructured":"Feldman HC, Merlini E, Guijas C, DeMeester KE, Njomen E, Kozina EM, et al. Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. Proc Natl Acad Sci U S A. 2022;119(35):e2208457119. https:\/\/doi.org\/10.1073\/pnas.2208457119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4198_CR48","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1021\/acs.jmedchem.4c03127","volume":"68","author":"M Giroud","year":"2025","unstructured":"Giroud M, Kuhn B, Steiner S, Westwood P, Mendel M, Mani A, et al. Discovery of a potent SARM1 base-exchange inhibitor with in vivo efficacy. J Med Chem. 2025;68(6):6558\u201375. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c03127.","journal-title":"J Med Chem"},{"issue":"6093","key":"4198_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.1223899","volume":"337","author":"JM Osterloh","year":"2012","unstructured":"Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, et al. dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 2012;337(6093):481\u20134. https:\/\/doi.org\/10.1126\/science.1223899.","journal-title":"Science"},{"issue":"9","key":"4198_CR50","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","volume":"82","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kerry PS, Nanson JD, Bosanac T, Sasaki Y, Krauss R, et al. Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules. Mol Cell. 2022;82(9):1643-1659.e10. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.007.","journal-title":"Mol Cell"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04198-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:50:06Z","timestamp":1793821806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04198-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4198"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04198-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Institutional Animals Ethics Committee (IAEC) of BITS-Pilani, Hyderabad campus, and conducted in compliance with the guidelines of the Committee for Control and Supervision of Experiments on Animals with CPCSEA registration no. 1912\/PO\/ReBi\/S\/2016\/CCSEA. The animal experiments were conducted as per the approved protocol no. BITS-HYD-IAEC-2025-053R.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial or personal interests that could have appeared to influence the work conducted in this publication.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}